Literature DB >> 23927937

Insights into antibody-associated encephalitis--Bickerstaff's 1950's papers revisited.

A Merwick1, J Dalmau, N Delanty.   

Abstract

Edwin Bickerstaff and Philip Cloake reported in the 1950's three cases of reversible encephalitis. The concept of antibody associated encephalitis had not been proposed at the time they astutely recognized the importance of disease pattern recognition and postulated a potential immune based mechanism. The syndrome defined by Bickerstaff of progressive, external ophthalmoplegia and ataxia, with disturbance of consciousness or hyperreflexia, has subsequently been associated with anti-GQ1b antibodies. Interestingly one of the three original cases, a young woman who developed seizures, an eye movement disorder and acute psychosis while awaiting ovarian cystectomy, has features that may be more consistent with anti-NMDA receptor encephalitis.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-NMDA receptor antibodies; Ataxia; Bickerstaff's brainstem encephalitis; Clinical history; Ophthalmoplegia; Psychosis

Mesh:

Substances:

Year:  2013        PMID: 23927937     DOI: 10.1016/j.jns.2013.07.010

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Edwin Bickerstaff (1920-2008).

Authors:  Manisha Yedla; Daniel V Lazzareschi; Jonathan D Santoro
Journal:  J Neurol       Date:  2016-09-26       Impact factor: 4.849

2.  NMDA receptor antibodies associated with distinct white matter syndromes.

Authors:  Yael Hacohen; Michael Absoud; Cheryl Hemingway; Leslie Jacobson; Jean-Pierre Lin; Mike Pike; Sunil Pullaperuma; Ata Siddiqui; Evangeline Wassmer; Patrick Waters; Sarosh R Irani; Camilla Buckley; Angela Vincent; Ming Lim
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2014-04-24

Review 3.  A clinical approach to diagnosis of autoimmune encephalitis.

Authors:  Francesc Graus; Maarten J Titulaer; Ramani Balu; Susanne Benseler; Christian G Bien; Tania Cellucci; Irene Cortese; Russell C Dale; Jeffrey M Gelfand; Michael Geschwind; Carol A Glaser; Jerome Honnorat; Romana Höftberger; Takahiro Iizuka; Sarosh R Irani; Eric Lancaster; Frank Leypoldt; Harald Prüss; Alexander Rae-Grant; Markus Reindl; Myrna R Rosenfeld; Kevin Rostásy; Albert Saiz; Arun Venkatesan; Angela Vincent; Klaus-Peter Wandinger; Patrick Waters; Josep Dalmau
Journal:  Lancet Neurol       Date:  2016-02-20       Impact factor: 44.182

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.